INIrena Netikova

Irena Netikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irena Netikova has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide

    by Irena R Štenglová Netíková, Luboš Petruželka, Martin Šťastný, Václav Štengl

    Introduction: Macrocrystalline oxides of alkaline earth metals (Mg and Ca) or light metals (Al and Ti) can respond to standard warfare agents such as sulfur mustard, soman, or agent VX. In this paper, we compared the decontamination ability of sodium hydroxide (NaOH) and sodium hypochlorite (NaClO) for nitrogen mustards (cyclophosphamide [CP] and ifosfamide [IFOS]) with a new procedure using a destructive sorbent based on nanocrystalline and nanodispersive titanium dioxide (TiO2) as a new efficient and cheap material for complete decontamination of surfaces. Methods: Titanium (IV) dioxide nanoparticles were prepared by the homogeneous hydrolysis of titanium(IV) oxysulfate (TiOSO4) with urea. The as-prepared TiO2 nanoparticles were used for the fast and safe decontamination of cytostatics from the nitrogen mustard family (CP and IFOS) in water. The adsorption–degradation process of cytostatics in the presence of TiO2 was compared with decontamination agents (0.01 M solution of sodium hydroxide and 5% solution of sodium hypochlorite). The mechanism of the decontamination process and the degradation efficiency were determined by high-performance liquid chromatography with mass spectrometry. Results: It was demonstrated that a 0.01 M solution of sodium hydroxide (NaOH) decomposes CP to 3-((amino(bis(2-chloroethyl)amino)phosphoryl)oxy)propanoic acid and sodium hypochlorite formed two reaction products, namely, IFOS and 4-hydroxy-cyclophosphamide. IFOS is cytotoxic, and 4-hydroxy-cyclophosphamide is a known metabolite of CP after its partial metabolism by CYP/CYP450. IFOS degrades in the pres¬ence of NaOH to toxic IFOS mustard. Titanium(IV) dioxide nanoparticles adsorbed on its surface CP after 5 minutes and on IFOS after 10 minutes. The adsorption–degradation process of CP in water and in the presence of TiO2 led to 4-hydroxy-cyclophosphamide and IFOS, respectively, which decayed to oxidation product 4-hydroxy-ifosfamide. Conclusion: Nanodispersive TiO2 is an effective degradation agent for decontamination of surfaces from cytostatics in medical facilities.


  • Creatinine Clearance Estimations for Vancomycin Maintenance Dose Adjustments

    by Martin Šíma, Jan Hartinger, Irena Štenglová Netíková, Ondřej Slanař


  • Open Access

    Anthracycline antibiotics derivate mitoxantrone—Destructive sorption and photocatalytic degradation

    by Irena R Štenglová-Netíková, Luboš Petruželka, Martin Šťastný, Václav Štengl

    Nanostructured titanium(IV) oxide was used for the destructive adsorption and photocatalytic degradation of mitoxantrone (MTX), a cytostatic drug from the group of anthracycline antibiotics. During adsorption on a titania dioxide surface, four degradation products of MTX, mitoxantrone dicarboxylic acid, 1,4-dihydroxy-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-8-((2-(methylamino)ethyl)amino)anthracene-9,10-dione, 1,4-dihydroxy-5,8-diiminoanthracene-9,10(5H,8H)-dione and 1,4-dihydroxy-5-imino-8-(methyleneamino)anthracene-9,10(5H,8H)-dione, were identified. In the case of photocatalytic degradation, only one degradation product after 15 min at m/z 472 was identified. This degradation product corresponded to mitoxantrone dicarboxylic acid, and complete mineralization was attained in one hour. Destructive adsorbent manganese(IV) oxide, MnO2, was used only for the destructive adsorption of MTX. Destructive adsorption occurred only for one degradation product, mitoxantrone dicarboxylic acid, against anatase TiO2.


  • Immunomonitoring in patients with stage II and III colon cancer.

    by Michal Vocka, Jan Spacek, Irena Netikova, Eva Zavadova, Kristýna Němejcová, Bohuslav Konopasek, Pavel Dundr, Carol-Immanuel Geppert, Terezie Fucikova, Arndt Hartmann, et al.

    E23038 Background: Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Immunoscore has been shown to be a very powerful prognositc indicator in patients with clinically localized colorectal cancer, with no detectable tumour spread to lymph nodes or distant organs. These patients are usually treated with only surgical removal of the tumour; however, approximately 25% of these patients will have recurrence of their disease, indicating that occult metastases were already present at the time of curative surgery. VEGF is the factor responsible for neoangiogenesis and it is being considered as a possible prognostic marker of disease progression. Transforming growth factor-beta (TGF-beta) is also neoangiogenic and a highly immunosuppressive factor. The purpose of this study was to monitor the immune response in patients with stage II and III CRC, with a focus on cellular as well as humoral immunity. TGF-beta and VEGF levels were followed. Methods: 25 patients with stage II and III colon cancer included in the research project received routine cancer teratment. Basic parameters - histological type and grade - were established at baseline. Patients were evaluated by a clinical immunooncolgist to exclude any immune disorders of allergic or autoimmune origin. TGF-beta and VEGF were measured using ELISA, and anti-tumour cellular immunity (CD4, CD8, T-reg, B cells ) were measured via flow cytometry. Results: In patients with stage II and III colorectal cancer, predominantly a depression in cellular immunity was seen. Plasma levels of immunglobulins were also reduced, particularly the IgG4 subtype. Most patients showed some clinical symptoms of immunodeficiency, such as frequent respiratory tract infections and/or herpetic infections. TGF-beta and VEGF plasma levels were increased. Conclusions: The correlation of these neoangiogenic and immunosuppressive factors, as well as the state of anticancer immunity with the clinical outcome of the patients, could help in the future as a prognostic marker and contribute to the selection of targeted immune therapy in patients with colorectal cancer. Dedication: Ggrant of Czech Ministery of Health, 15-28188A, League against cancer and PRVOUK-P-27/LF1/1

  • A new possible way of anthracycline cytostatics decontamination

    by Irena R. Štenglová Netíková, Michaela Slušná, Jakub Tolasz, Martin Št'AStný, Štěpán Popelka, Václav Štengl

    The widespread use of cytotoxic drugs in the treatment of cancer has led to the production of large amounts of contaminated wastes with high exposure risk of medical staff handling cytostatics. For this reason it is essential to use a highly effective and fast decontaminating agent for the decontamination process. Currently used decontamination agents based on NaOCl and NaOH are not sufficient according to our results and also according to literature data. Therefore we have developed a new decontamination agent based on titania nanoparticles, which appears to be a very efficient and fast decontamination agent according to our research data. Anthracycline antibiotics are valuable and frequently used drugs in various chemotherapeutic schemes. They have high efficacy, but also high toxicity, e.g. myelosuppression and cardiotoxicity. They can also act as vesicants in the case of extravasation. Due to their mechanism of action, anthracycline antibiotics have mutagenic and carcinogenic effects. Long term contact, even with a trace amount, can cause changes in human health. Safe decontamination of cytotoxic drug contaminated areas with an agent, which can cause degradation to non-toxic products, is essential. High sorption ability of doxorubicin and epirubicin to titania predisposes TiO2 to become a new, effective and inexpensive agent for area decontamination and degradation of anthracycline antibiotics.


  • Viability of tumor cells of breast carcinoma incubated with carbon nanostructures.

    by Irena Netikova, Jan Hartinger, Lubos B. Petruzelka, Jakub Tolasz, Petr Vomacka, Vaclav Stengl

    E23185 Background: The study results show that surfaces treated with carbon nanostructures such as fullerenes, carbon nanotubes, graphene and graphene oxide in themselves exhibit antibacterial properties. Suitably functionalized carbon nanotubes, graphene and graphene oxide mainly may be used as carriers for cytostatic agents in the targeted treatment of oncological diseases. Methods: Cells from the breast cancer cell line and lung epithelial cells were exposed to aqueous colloidal solutions of graphene oxide and single walled carbon nanotubes (SWCN), then incubated and examined the effect of graphene oxide and carbon nanotubes on viability and structural changes in cells. The graphene oxide we prepared direct from graphene using sulphuric acid, pottasium permanganate and phosphoric acid, The bio-distribution of nanoparticles into the cell body to the subcellular level was monitored by Raman spectroscopy and high resolution transmission electron microscopy. As a model cell population for our study a clonal cell line, EM-G3 and A549 lung epithelial cells (ATCC CCL-185; American Type Culture Collection) was used. The EM-G3 line was derived from a primary lesion of human infiltrating ductal breast carcinoma. Cells were cultured in RPMI-1640 supplemented with 10% fetal calf serum and gentamicin at 37°C in a humidified atmosphere with 5% CO2 . Results: Nanoparticles are unlike other particles able to enter biological membranes into cells, tissues and organs. They penetrate into mitochondria and cell nuclei and influenced the tumor cell viability. Cell viability is significantly decreased with incubation with single- walled carbon nanotubes and multiwalled carbon nanotubes. Incubation with graphene and graphene oxide respectively increase the cell viability and proliferation. Conclusions: Studies have proven the possibility of carbon nanotubes to induce DNA mutations and structural changes, even leading to cell death. In opposite graphene and graphene oxide don’t casue serious DNA damage and increase cell viabillity in vitro. Using phosphoric acid instead toxic chlorates and nitrates at graphene oxyide synthsis enable prepare biologically adaptable graphene oxide.

  • http://www.linkos.cz/klinicka-onkologie-journal/search-for-articles/skupina/a/zobrazit/ids/4854/

    by Eva Závadová, Jiří Špaček, Michal Vočka, Bohuslav Konopásek, Jitka Fučíková, Irena Netíková, Pavel Dundr, Helena Skálová, Luboš Petruželka


    • 1 March 2015
      • Vol. 35  (3) , 1303-10

    The protective effect of pyrimidine nucleosides on human HaCaT keratinocytes treated with 5-FU.

    by Jan Hartinger, Pavel Vesely, Irena Stenglova Netíková, Eva Matoušková, Luboš Petruželka

    Therapy with 5-fluorouracil (5-FU) and capecitabine is often complicated by skin toxicity (hand-foot syndrome, HFS). Topical application of uridine ointment is beneficial for alleviating HFS and other pyrimidine nucleosides have been described as 5-FU toxicity modulators. We tested pyrimidine nucleosides and their combinations to find the best combination for topical therapy of HFS. Cellular viability was measured by the real-time cell analyser and methyl thiazol tetrazolium (MTT) assay in order to evaluate the effect of pyrimidine nucleosides on HaCaT keratinocytes treated with 5-FU. The results were confirmed by evaluation of the cellular colonization by microphotography. Cytidine and uridine protected keratinocytes to the same extent. Thymidine enhanced the protective effect when added to cytidine or uridine. Deoxycytidine did not have any protective effect. Our findings support the rationale for using uridine or cytidine in combination with thymidine in ointment for HFS treatment.


  • Open Access

    Pregnane Xenobiotic Receptors and Their Effect on Drug Elimination from the Organism

    by Martin Šíma, I. Netíková, O. Slanař

    Nuclear receptors are intracellular proteins which, having been activated by their more or less specific ligands, regulate (usually increase) the transcription of target genes. They thus participate in a regulation of a number of physiologic functions. Some of them – especially pregnane xenobiotic receptors – serve primarily as protection of the organism from the xenobiotic intoxication. This is because many xenobiotics activate their function which consists in increasing the gene expression of enzymes involved in the metabolism of xenobiotics and detoxication drug transporters. Clarification of these mechanisms enabled the understanding of the substance of many drug-drug interactions observed in the clinical practice. Polymorphism of the nuclear receptors appears to be one of the causes of the interindividual variability in response to drug administration.


  • Open Access

    Local Treatment of Hand-Foot Syndrome with Uridine/Thymidine:In VitroAppraisal on a Human Keratinocyte Cell Line HaCaT

    by J. Hartinger, P. Veselý, E. Matoušková, S. Argalacsová, L. Petruželka, I. Netíková

    5-fluorouracil (5-FU) is one of the most commonly used antineoplastic drugs in the anticancer therapy. The hand-foot (HF) syndrome (palmar-plantar erythrodysesthesia) is an adverse effect frequently related to long-term i.v. administration of 5-FU or its orally applicable prodrug capecitabine. Its severity can even lead to interruption of the otherwise effective anticancer therapy. Tentative practice in some clinics has shown that topical application of 10% uridine ointment is beneficial for calming down the HF syndrome. This study is focused on verifying the alleged protective activity of uridine in thein vitromodel of cultured human keratinocyte cell line HaCaT. We also tested the protective effects of thymidine alone or uridine-thymidine combination. The cellular viability time progression was measured in order to evaluate the effect of protective agents by three different types of cytopathogenicity tests—NTCA test (non-destructive test of cellular activity), modified MTT test and RTCA (real-time cell analyser, Roche). All three methods proved the ability of uridine and uridine-thymidine combination to protect keratinocytes against 5-FU damagein vitro. While thymidine alone did not show any remarkable effect, the thymidine-uridine combination demonstrated enhanced protective activity compared to uridine alone. Our findings provided the supporting rationale for using uridine or uridine-thymidine ointments in the HF syndrome local therapy.